Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
drug pricing
2
×
gene therapy
life sciences
novartis
spinal muscular atrophy
zolgensma
2
×
billy dunn
biogen
bioinnovation capital
biolabs
boston
boston blog main
chemotherapy
clinical trials
daraprim
drug prices
drugs
epipen
epipens
europe top stories
evrysdi
exome
fda
genentech
generic drugs
insulin
ionis pharmaceuticals
johannes fruehauf
labcentral
life science
martin shkreli
mylan
national
national blog main
national top stories
national xcon
new york top stories
nusinersen
oncology
What
drug
approved
atrophy
biotech
daily
driving
evrysdi
fda
friday
good
green
healthcare
history
home
improved
industry
innovation
innovations
intended
investment
life
lights
liquid
long
medical
medicine
muscular
new
oral
outcomes
patients
pricing
proud
public
risdiplam
roche
sciences
spinal
therapy
wide
Language
unset
Current search:
zolgensma
×
" drug pricing "
×
@xconomy.com
3 years ago
FDA Green-Lights Roche Spinal Muscular Atrophy Drug, First Oral Therapy
@xconomy.com
4 years ago
Drug Pricing: Innovation, Investment, and the Public Good
